Research analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report issued on Monday. The brokerage set a “buy” rating on the stock.
Mannatech Stock Performance
Shares of Mannatech stock opened at $7.67 on Monday. Mannatech has a 12 month low of $6.75 and a 12 month high of $15.10. The firm has a market capitalization of $14.42 million, a P/E ratio of -8.62 and a beta of 1.17. The company has a current ratio of 1.08, a quick ratio of 0.56 and a debt-to-equity ratio of 0.09. The business has a fifty day simple moving average of $7.38 and a two-hundred day simple moving average of $8.14.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings results on Tuesday, May 14th. The company reported $0.63 earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 1.31% and a negative return on equity of 15.37%. The company had revenue of $29.39 million during the quarter.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Recommended Stories
- Five stocks we like better than Mannatech
- What is the S&P/TSX Index?
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- What is the S&P 500 and How It is Distinct from Other Indexes
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.